Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
8.63
+0.53 (6.54%)
At close: Aug 1, 2025, 4:00 PM
8.50
-0.13 (-1.51%)
After-hours: Aug 1, 2025, 6:40 PM EDT
Verve Therapeutics Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$20.07
Upside
+132.56%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +143.34% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $24 | Buy | Initiates | $24 | +178.10% | Jul 28, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +85.40% | Jul 16, 2025 |
| Wedbush | Wedbush | Buy Reiterates $18 | Buy | Reiterates | $18 | +108.57% | Jun 23, 2025 |
| Raymond James | Raymond James | Buy Initiates $14 | Buy | Initiates | $14 | +62.22% | Jun 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +15.87% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +154.92% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +154.92% | Mar 5, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +201.27% | Feb 25, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $22 | Buy | Maintains | $19 → $22 | +154.92% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +154.92% | Nov 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $36 | Strong Buy | Maintains | $17 → $36 | +317.15% | Nov 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $19 → $22 | Strong Buy | Maintains | $19 → $22 | +154.92% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +154.92% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $15 | Hold | Maintains | $7 → $15 | +73.81% | Oct 21, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $13 → $17 | Buy | Maintains | $13 → $17 | +96.99% | Oct 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.